Tools
Pulmonary Rehabilitation
Introduction
Pulmonary rehabilitation (PR) is a “comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies that include, but are not limited to exercise training, education, and behavior change, designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviors” as per the official American Thoracic Society/ European Respiratory Society statement.[1]
In the National Emphysema Treatment Trial (NETT), it was noted that pulmonary rehabilitation showed benefits in patients with COPD. These patients underwent pulmonary rehabilitation before and after lung volume reduction surgery.[2] No significant improvements in mortality or lung function were presumed as a lack of its efficacy of pulmonary rehabilitation in the past. The use of meaningful endpoints such as exercise tolerance, symptoms of dyspnea, endurance, and quality of life has changed the outlook at pulmonary rehabilitation. When the goals of pulmonary rehabilitation were readdressed, the benefits became clearer.
Anatomy and Physiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Anatomy and Physiology
Limitations in work capacity are noted in patients with advanced lung disease due to impaired gas exchange and alveolar ventilation. The resulting decrease in oxygen supply to skeletal muscles can shift towards anaerobic metabolism in the skeletal muscles and build-up of lactic acid.[3] Additionally, there is a decrease in aerobic enzyme activity and a lower fraction of aerobic muscle fibers (Type I).[4]
A program involving high-intensity exercises can bring about biochemical changes at the cellular level and structural changes in the muscle fibers leading to more aerobic metabolism and a decrease in lactic acid and carbon dioxide production. This leads to delayed onset of fatigue and enhanced exercise tolerance.[3][5]
Indications
Pulmonary rehabilitation benefits patients with chronic lung disease and can be beneficial to patients irrespective of the severity of the lung disease. The majority of earlier literature on pulmonary rehabilitation involves patients with advanced COPD (chronic obstructive pulmonary disease) as it was developed and implemented for them. However, lung function should not be the sole criterion. The selection of patients for pulmonary rehabilitation should be based on symptoms and functional limitations. Patients with mild to moderate COPD also benefit from pulmonary rehabilitation.[6]
With its benefit in COPD, pulmonary rehabilitation has been extended to other pulmonary disease processes such as asthma, bronchiectasis, interstitial lung diseases, chest wall disorders, and pulmonary hypertension.[7][8][9][10] Additionally, pulmonary rehabilitation can have a significant impact on patients enrolled in lung transplantation. It is employed pre and post-transplant as part of the comprehensive transplant plan.[11]
According to the recommendations of the American College of Chest Physicians and American Association of Cardiovascular and Pulmonary Rehabilitation (ACCP/AACVPR) practice guidelines, "pulmonary rehabilitation is appropriate for any stable patient with a chronic lung disease who is disabled by respiratory symptoms."[12]
Contraindications
Sometimes, certain underlying medical and physical conditions can prevent patients from effectively participating in the rehabilitation program. Some examples include angina pectoris, decompensated congestive health failure, acute cor-pulmonale, inability to perform exercises due to severe orthopedic impairments, and severe cognitive deficits. Individualized evaluation and plan for patients with potential roadblocks to pulmonary rehabilitation are essential.[3]
Equipment
The pulmonary rehabilitation program can be conducted in the hospital, outpatient, or home. The ability to provide rehabilitation in different settings can help assist patients with varying severity of pulmonary impairments. Equipment for exercise and monitoring are essential components of the program, and they vary depending on the location and setting. Exercise equipment usually includes a treadmill, stationary bicycle, access to stairs or step box, arm crank ergometer, hand weights, resistive exercise bands, and weights. Most researches on the benefits of pulmonary rehabilitation are based on cycle ergometers and treadmills for endurance training and weight machines for resistance training.[13] Essential monitoring devices needed include a pulse oximeter, sphygmomanometer, and tape to measure incremental shuttle walk.
Personnel
Even though no clear guidelines exist regarding the structure of the team itself, several key members are essential to developing a successful pulmonary rehabilitation program. The team usually includes providers, physiotherapists, occupational therapists, respiratory therapists, exercise physiologists, nurses, psychologists, behavior specialists, nutritionists, and social workers. This allows for a multi-modal approach.
The provider in charge serves as the medical director, who is responsible for the intake assessment, development of the plan along with the team, and monitoring of the progress and necessary adjustments to the treatment protocol. The psycho-social morbidity associated with progressive advanced lung disease needs to be understood when making treatment plans. A decrease in anxiety, depression, and improvement in cognition has been demonstrated with comprehensive pulmonary rehabilitation.[13] Thus, input from psychologists and social workers is an essential part of pulmonary rehabilitation as much as exercises and the physical aspect of it.
Preparation
The patient selection process involves evaluating patients' diagnosis and disease severity based on pulmonary function tests. Initial assessment of every patient includes- Borg scale of perceived exertion during supervised baseline incremental exercise test, dyspnea scores during initial maximal exercise capacity, a baseline 6-minute walk test, and Saint George Respiratory Questionnaire (SGRQ) to estimate the quality of life.[13][14][15]
An individualized exercise program is developed based on the assessments mentioned above. Additionally, it is necessary to evaluate the need for supplemental oxygen, rule out cardiovascular limitations, and also assess the safety of exercise interventions. Although a formal cardiopulmonary exercise testing is not necessary for all patients, it helps assess factors contributing to exercise limitations, the safety of exercise, and also prescribing appropriate exercise plan.[14] It may also help in assessing exercise-induced bronchospasm, unmasking cardiac dysrhythmias, and cardiac ischemia.[15][14]
Technique or Treatment
Exercise training focusing on endurance, strength training, and flexibility is the cornerstone of pulmonary rehabilitation. The load during exercise is assessed based on initial assessment and also individual requirements. The load must reflect an individual's daily requirements and escalate as the exercise program progresses incrementally with close monitoring. The goal is to improve patients' aerobic capacity and muscle strength.[1] The crux of endurance training is the conditioning of muscles of ambulation and augmentation of cardiorespiratory fitness, translating to an increase in physical activity with decreased dyspnea and fatigue.[1][16]
Cycling and walking exercises remain the most common form of endurance exercises.[1] Frequency of three to five times per week is recommended for endurance exercise training at an intensity of more than 60% maximal work rate for 20 to 60 minutes.[17] The target training intensity is approximately a Borg dyspnea score of 4 to 6 or a rating of perceived exertion of 12 to 14, which is considered moderate to severe intensity.[18] Interval training is an alternate option to standard endurance training in individuals who have difficulty with continuous training. In interval training, periods of intense training are separated by rest or training at a lower intensity. It also allows achieving most of the benefits of endurance training while reducing dyspnea and fatigue.[19][20][21]
Resistance training/strength training is another modality of exercise used in pulmonary rehabilitation. It involves training with resistive loads with repetitions, and loads are increased progressively to achieve maximal benefits.[22] Lesser dyspnea is noted in resistance training compared to endurance training and is sometimes better tolerated by patients.[23] Resistance training also helps improve muscle mass and bone mineral density.[24][25][26] The American College of Sports Medicine recommends 1 to 3 sets of 8 to 12 repetitions done on 2 or 3 days each week to improve muscle strength as part of resistance training.[27] About 60 to 70% of one-repetition maximum is considered a suitable initial load.[28]
The exercise load and repetitions are increased over time in a supervised fashion to help build up strength, muscle mass, and endurance.[27] The best strategy is to include endurance training or interval training along with resistance training in an individual exercise plan as it is known to confer the best benefit than individuals components by themselves.[29] Supplemental oxygen delivery during exercise depends on patients' requirements during rest and during exercise. It has been noted that in COPD patients, supplemental oxygen during exercise in hypoxemic and even in non-hypoxemic patients results in improved exercise tolerance and higher intensity training. It may be due to a decrease in pulmonary artery pressures, carotid body inhibition, and decreased ventilatory drive, and also reduced lactic acid production.[1][30]
Pulmonary rehabilitation is not limited to exercise only. Education, psychosocial support, and nutrition are crucial to achieving patient well-being. Advanced lung diseases have significant psychological and social impacts. It may be more severe if patients need supplemental oxygen.[31] Anxiety and depression are noted among patients with progressive chronic lung diseases.[32]
Alterations in functionality and social life can worsen deconditioning and motivation needed to participate in pulmonary rehabilitation exercises. Hence, it is equally important to focus on the psychological impact of the disease. Pulmonary rehabilitation confers significant benefits in anxiety and depression associated with COPD and also other chronic lung diseases.[13] Breathing techniques are also discussed with the patients to help reduce anxiety and panic. Patients are often screened for untreated depression and anxiety via standardized questionnaires and assessed post-rehabilitation for improvements.[33] If needed, referrals are made to psychologists to help in the management of these co-morbidities.
Nutrition and education are other aspects of pulmonary rehabilitation that are integral to the success of the program. Weight loss and muscle mass loss is a common occurrence in advanced pulmonary diseases. This is multifactorial, often related to increased load on respiratory muscles and also poor oral intake.[34] Detailed dietary history and nutritionist input are helpful in many patients. Patient education involving an understanding of the disease process, treatment options, and rationale, self-management, the role of supplemental oxygen helps participants feel empowered and become active participants in the program.[35]
A written individualized action plan is part of the educational component of the pulmonary rehabilitation program. It involves understanding the symptoms of exacerbations and triggers. It has management strategies for early exacerbations.[36] Many of the patients enrolled in pulmonary rehabilitation have advanced progressive lung disease with other co-morbidities. Advanced care planning is an aspect of comprehensive care that is often overlooked. Advanced care planning involves discussions related to patient care but not restricted to end of life care and advanced directives.[37][38] It can also include discussions about the process of dying and the prevention of suffering.[1]
A maintenance strategy is essential in a pulmonary rehabilitation program. Without a maintenance plan, the benefits appear to diminish by 6-12 months. Quality of life is maintained slightly better than exercise capacity.[39] The maintenance program should include home exercises, a plan for managing the disease process, and a robust psychosocial support network. A structured program with maintenance exercise and self-management plan is essential to have sustained benefits. Ultimately the goal of a pulmonary rehabilitation program is to create a lifestyle change. This requires a dedicated plan followed by continuous reinforcement.
Complications
Complications from pulmonary rehabilitation are mostly due to improper patient selection. Following patient selection, it is essential to create a safe and effective individualized plan. It is vital to screen the participants for co-morbidities, as many of the patients with advanced lung diseases have cardiac and musculoskeletal ailments. Cardiovascular ischemic events and arrhythmias in patients at risk who were not appropriately screened.
Vitals and oxygen levels require monitoring during exercises, and supplemental oxygen should be provided and titrated as needed. The patient's limitations due to muscle wasting and weakness have to be considered to avoid falls and injuries. If available, cardiopulmonary exercise testing before enrollment might help unmask underlying ischemia, cardiac dysrhythmias, musculoskeletal issues.[14] However, most complications can be avoided with appropriate patient selection, careful planning, and close monitoring.
Clinical Significance
The benefits of the pulmonary rehabilitation program are measured using different parameters. Most of the initial studies in pulmonary rehabilitation were done in patients with COPD, but that has changed recently. Pulmonary rehabilitation is being utilized for patients with different lung diseases, and outcomes may be driven inherently by the underlying disease process.
Survival benefit is one of the important outcomes looked at in pulmonary rehabilitation. In one study, pulmonary rehabilitation initiated within three months of hospital discharge was noted to have a lower risk of mortality at one year; however, other studies have challenged that.[40][41] Quality of life and exercise capacity are important parameters that can be measured. Pulmonary rehabilitation has been shown to improve quality of life as measured on the Chronic Respiratory Disease Questionnaire (CRQ) and St. George's Respiratory Questionnaire (SGRQ).[42][43]
Multiple studies have shown improvements in maximal exercise capacity and functional exercise capacity with pulmonary rehabilitation in patients with various chronic lung diseases, including post-lung transplant.[44][45][46] Pulmonary rehabilitation was shown to affect the decline of FEV1 over time in COPD patients.[47] Psychosocial benefits from rehabilitation are as important as physical benefits as they are interconnected. Worsening depression and anxiety can adversely affect a person's ability to partake in rehabilitation activities and continuing maintenance programs. Multiple studies have shown clinically relevant improvement in anxiety and depression symptoms.[13]
Chronic respiratory diseases, such as COPD, also have a major monetary impact. Healthcare costs attributable to COPD are estimated to reach approximately $49 billion by 2020 as per the Center for Disease Control (CDC).[48] It includes all aspects of care, including frequent emergency room visits, hospital admissions, exacerbations, and medications. Besides pharmacological interventions, pulmonary rehabilitation is a useful tool that can help reduce exacerbations, readmissions, and hospital length of stay. A written action plan helps reduce health care utilization, costs, and early recovery by early recognition and treatment of exacerbations.[49] The multidisciplinary approach in a pulmonary rehabilitation program can decrease the use of health services and readmissions.[36][50][51]
With smoking contributing to the bulk of the COPD cases and its role in the progression of the disease, pulmonary rehabilitation program provides a unique opportunity to address smoking cessation. Smokers are motivated to stop smoking in a rehabilitation environment with the effects of positive reinforcement.[52] Smoking cessation is often a part of the action plan at the program. The availability of multiple disciplines in pulmonary rehabilitation also provides an opportunity for patients to partake in advanced care planning. Patients enrolled in pulmonary rehabilitation were conducive to having a more detailed advanced care discussion.[53]
With the increasing volume of evidence in favor of early initiation of pulmonary rehabilitation, the British Thoracic Society guidelines recommend that patients hospitalized for acute exacerbation of COPD should be offered pulmonary rehabilitation at hospital discharge to commence within one month of discharge.[54]
Enhancing Healthcare Team Outcomes
A pulmonary rehabilitation program is a multi-disciplinary team-based intervention. It involves the input of various professionals who work towards a common goal, and studies have shown that working as a team helps improve outcomes.[55] [Level 3]
The initial assessment and plan take into account the input of a provider from a clinical standpoint. An exercise physiologist working with a physical therapist helps plan the exercise program. Respiratory therapists help with patients’ underlying lung disease and breathing techniques to provide symptom relief.
Psychiatrists and psychologists' assessment before, during, and after is important as depression, anxiety and mental health issues associated with chronic diseases need to be addressed concurrently. Social workers help with addressing issues at home and social hindrances in achieving the ultimate goal of delivering high-quality care. No intervention is successful without a proper follow-up, appropriate medication reconciliation, and education which is imparted by a nursing team.
Many of the professionals in the team are not locked in their roles. Working in a team, they can identify and often fill in the roles of other team members. In a system with so many moving parts, communication is the key. Roadblocks in each step or intervention have to be discussed with other members of the team as it helps in problem-solving and customizing it to patients' needs. Periodic meetings are beneficial to discuss the progress and modifications needed.
References
Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF, ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American journal of respiratory and critical care medicine. 2013 Oct 15:188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Epub [PubMed PMID: 24127811]
Level 3 (low-level) evidenceRies AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, Fishman AP, National Emphysema Treatment Trial Research Group. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest. 2005 Dec:128(6):3799-809 [PubMed PMID: 16354848]
Level 1 (high-level) evidenceSharma BB, Singh V. Pulmonary rehabilitation: An overview. Lung India : official organ of Indian Chest Society. 2011 Oct:28(4):276-84. doi: 10.4103/0970-2113.85690. Epub [PubMed PMID: 22084542]
Level 3 (low-level) evidenceAgustí AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2002 Aug 15:166(4):485-9 [PubMed PMID: 12186825]
Level 2 (mid-level) evidenceCasaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. The New England journal of medicine. 2009 Mar 26:360(13):1329-35. doi: 10.1056/NEJMct0804632. Epub [PubMed PMID: 19321869]
Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA, Spruit MA, Masefield S, Casaburi R, Clini EM, Crouch R, Garcia-Aymerich J, Garvey C, Goldstein RS, Hill K, Morgan M, Nici L, Pitta F, Ries AL, Singh SJ, Troosters T, Wijkstra PJ, Yawn BP, ZuWallack RL, ATS/ERS Task Force on Policy in Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. American journal of respiratory and critical care medicine. 2015 Dec 1:192(11):1373-86. doi: 10.1164/rccm.201510-1966ST. Epub [PubMed PMID: 26623686]
Ferreira G, Feuerman M, Spiegler P. Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease. Journal of cardiopulmonary rehabilitation. 2006 Jan-Feb:26(1):54-60 [PubMed PMID: 16617229]
Level 2 (mid-level) evidenceNewall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax. 2005 Nov:60(11):943-8 [PubMed PMID: 15994254]
Level 1 (high-level) evidenceAndo M, Mori A, Esaki H, Shiraki T, Uemura H, Okazawa M, Sakakibara H. The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder. Chest. 2003 Jun:123(6):1988-95 [PubMed PMID: 12796179]
Uchi M, Saji T, Harada T. [Feasibility of cardiopulmonary rehabilitation in patients with idiopathic pulmonary arterial hypertension treated with intravenous prostacyclin infusion therapy]. Journal of cardiology. 2005 Nov:46(5):183-93 [PubMed PMID: 16320975]
Level 2 (mid-level) evidenceAdegunsoye A, Strek ME, Garrity E, Guzy R, Bag R. Comprehensive Care of the Lung Transplant Patient. Chest. 2017 Jul:152(1):150-164. doi: 10.1016/j.chest.2016.10.001. Epub 2016 Oct 8 [PubMed PMID: 27729262]
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007 May:131(5 Suppl):4S-42S [PubMed PMID: 17494825]
Level 1 (high-level) evidenceGordon CS, Waller JW, Cook RM, Cavalera SL, Lim WT, Osadnik CR. Effect of Pulmonary Rehabilitation on Symptoms of Anxiety and Depression in COPD: A Systematic Review and Meta-Analysis. Chest. 2019 Jul:156(1):80-91. doi: 10.1016/j.chest.2019.04.009. Epub 2019 Apr 26 [PubMed PMID: 31034818]
Level 1 (high-level) evidenceAmerican Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. American journal of respiratory and critical care medicine. 2003 Jan 15:167(2):211-77 [PubMed PMID: 12524257]
Level 3 (low-level) evidenceCrapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. American journal of respiratory and critical care medicine. 2000 Jan:161(1):309-29 [PubMed PMID: 10619836]
Level 1 (high-level) evidenceLacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2006 Oct 18:(4):CD003793 [PubMed PMID: 17054186]
Level 1 (high-level) evidenceGarber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP, American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Medicine and science in sports and exercise. 2011 Jul:43(7):1334-59. doi: 10.1249/MSS.0b013e318213fefb. Epub [PubMed PMID: 21694556]
Level 2 (mid-level) evidenceHorowitz MB, Littenberg B, Mahler DA. Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest. 1996 May:109(5):1169-75 [PubMed PMID: 8625662]
Kortianou EA, Nasis IG, Spetsioti ST, Daskalakis AM, Vogiatzis I. Effectiveness of Interval Exercise Training in Patients with COPD. Cardiopulmonary physical therapy journal. 2010 Sep:21(3):12-9 [PubMed PMID: 20957074]
Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. The European respiratory journal. 2002 Jul:20(1):12-9 [PubMed PMID: 12166558]
Level 1 (high-level) evidenceGloeckl R, Halle M, Kenn K. Interval versus continuous training in lung transplant candidates: a randomized trial. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012 Sep:31(9):934-41. doi: 10.1016/j.healun.2012.06.004. Epub [PubMed PMID: 22884381]
Level 1 (high-level) evidenceO'Shea SD, Taylor NF, Paratz JD. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest. 2009 Nov:136(5):1269-1283. doi: 10.1378/chest.09-0029. Epub 2009 Sep 4 [PubMed PMID: 19734323]
Level 1 (high-level) evidenceProbst VS, Troosters T, Pitta F, Decramer M, Gosselink R. Cardiopulmonary stress during exercise training in patients with COPD. The European respiratory journal. 2006 Jun:27(6):1110-8 [PubMed PMID: 16540501]
Schoenfeld BJ, Ogborn D, Krieger JW. Dose-response relationship between weekly resistance training volume and increases in muscle mass: A systematic review and meta-analysis. Journal of sports sciences. 2017 Jun:35(11):1073-1082. doi: 10.1080/02640414.2016.1210197. Epub 2016 Jul 19 [PubMed PMID: 27433992]
Level 1 (high-level) evidenceSimpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax. 1992 Feb:47(2):70-5 [PubMed PMID: 1549826]
Level 1 (high-level) evidenceGraat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF, CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respiratory medicine. 2009 Aug:103(8):1143-51. doi: 10.1016/j.rmed.2009.02.014. Epub [PubMed PMID: 19304474]
Level 2 (mid-level) evidenceAmerican College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Medicine and science in sports and exercise. 2009 Mar:41(3):687-708. doi: 10.1249/MSS.0b013e3181915670. Epub [PubMed PMID: 19204579]
Kaelin ME, Swank AM, Adams KJ, Barnard KL, Berning JM, Green A. Cardiopulmonary responses, muscle soreness, and injury during the one repetition maximum assessment in pulmonary rehabilitation patients. Journal of cardiopulmonary rehabilitation. 1999 Nov-Dec:19(6):366-72 [PubMed PMID: 10609187]
Level 3 (low-level) evidenceOrtega F, Toral J, Cejudo P, Villagomez R, Sánchez H, Castillo J, Montemayor T. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2002 Sep 1:166(5):669-74 [PubMed PMID: 12204863]
Level 2 (mid-level) evidenceEmtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. American journal of respiratory and critical care medicine. 2003 Nov 1:168(9):1034-42 [PubMed PMID: 12869359]
Level 1 (high-level) evidenceLacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. Journal of cardiopulmonary rehabilitation. 2001 Mar-Apr:21(2):80-6 [PubMed PMID: 11314288]
Level 2 (mid-level) evidencede Voogd JN, Wempe JB, Koëter GH, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009 Mar:135(3):619-625. doi: 10.1378/chest.08-0078. Epub 2008 Nov 24 [PubMed PMID: 19029432]
Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. The European respiratory journal. 2006 Apr:27(4):788-94 [PubMed PMID: 16481381]
Debigaré R, Marquis K, Côté CH, Tremblay RR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003 Jul:124(1):83-9 [PubMed PMID: 12853506]
Lenferink A, Brusse-Keizer M, van der Valk PD, Frith PA, Zwerink M, Monninkhof EM, van der Palen J, Effing TW. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2017 Aug 4:8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2. Epub 2017 Aug 4 [PubMed PMID: 28777450]
Level 1 (high-level) evidenceEffing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA. Self-management education for patients with chronic obstructive pulmonary disease. The Cochrane database of systematic reviews. 2007 Oct 17:(4):CD002990 [PubMed PMID: 17943778]
Level 1 (high-level) evidenceFried TR, Van Ness PH, Byers AL, Towle VR, O'Leary JR, Dubin JA. Changes in preferences for life-sustaining treatment among older persons with advanced illness. Journal of general internal medicine. 2007 Apr:22(4):495-501 [PubMed PMID: 17372799]
Level 2 (mid-level) evidenceJanssen DJ, Engelberg RA, Wouters EF, Curtis JR. Advance care planning for patients with COPD: past, present and future. Patient education and counseling. 2012 Jan:86(1):19-24. doi: 10.1016/j.pec.2011.01.007. Epub 2011 Feb 12 [PubMed PMID: 21316899]
Foglio K, Bianchi L, Bruletti G, Porta R, Vitacca M, Balbi B, Ambrosino N. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respiratory medicine. 2007 Sep:101(9):1961-70 [PubMed PMID: 17531455]
Lindenauer PK, Stefan MS, Pekow PS, Mazor KM, Priya A, Spitzer KA, Lagu TC, Pack QR, Pinto-Plata VM, ZuWallack R. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA. 2020 May 12:323(18):1813-1823. doi: 10.1001/jama.2020.4437. Epub [PubMed PMID: 32396181]
Kjærgaard JL, Juhl CB, Lange P, Wilcke JT. Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial. ERJ open research. 2020 Jan:6(1):. pii: 00173-2019. doi: 10.1183/23120541.00173-2019. Epub 2020 Feb 17 [PubMed PMID: 32083113]
Level 1 (high-level) evidenceMan WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ (Clinical research ed.). 2004 Nov 20:329(7476):1209 [PubMed PMID: 15504763]
Level 1 (high-level) evidenceDowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, Glaspole I, Goh NSL, Southcott AM, Burge AT, Gillies R, Martin A, Holland AE. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax. 2017 Jul:72(7):610-619. doi: 10.1136/thoraxjnl-2016-208638. Epub 2017 Feb 17 [PubMed PMID: 28213592]
Hanada M, Kasawara KT, Mathur S, Rozenberg D, Kozu R, Hassan SA, Reid WD. Aerobic and breathing exercises improve dyspnea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis. Journal of thoracic disease. 2020 Mar:12(3):1041-1055. doi: 10.21037/jtd.2019.12.27. Epub [PubMed PMID: 32274173]
Level 2 (mid-level) evidenceWickerson L, Mathur S, Brooks D. Exercise training after lung transplantation: a systematic review. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2010 May:29(5):497-503. doi: 10.1016/j.healun.2009.12.008. Epub 2010 Feb 4 [PubMed PMID: 20133160]
Level 1 (high-level) evidenceStiebellehner L, Quittan M, End A, Wieselthaler G, Klepetko W, Haber P, Burghuber OC. Aerobic endurance training program improves exercise performance in lung transplant recipients. Chest. 1998 Apr:113(4):906-12 [PubMed PMID: 9554624]
Level 3 (low-level) evidenceIncorvaia C, Russo A, Foresi A, Berra D, Elia R, Passalacqua G, Riario-Sforza GG, Ridolo E. Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study. European journal of physical and rehabilitation medicine. 2014 Aug:50(4):419-26 [PubMed PMID: 24691247]
Level 2 (mid-level) evidenceFord ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2015 Jan:147(1):31-45. doi: 10.1378/chest.14-0972. Epub [PubMed PMID: 25058738]
Level 2 (mid-level) evidenceTrappenburg JC, Monninkhof EM, Bourbeau J, Troosters T, Schrijvers AJ, Verheij TJ, Lammers JW. Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax. 2011 Nov:66(11):977-84. doi: 10.1136/thoraxjnl-2011-200071. Epub 2011 Jul 23 [PubMed PMID: 21785156]
Level 2 (mid-level) evidenceCalifornia Pulmonary Rehabilitation Collaborative Group. Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. Journal of cardiopulmonary rehabilitation. 2004 Jan-Feb:24(1):52-62 [PubMed PMID: 14758104]
Level 2 (mid-level) evidenceBhatt SP, Patel SB, Anderson EM, Baugh D, Givens T, Schumann C, Sanders JG, Windham ST, Cutter GR, Dransfield MT. Video Telehealth Pulmonary Rehabilitation Intervention in Chronic Obstructive Pulmonary Disease Reduces 30-Day Readmissions. American journal of respiratory and critical care medicine. 2019 Aug 15:200(4):511-513. doi: 10.1164/rccm.201902-0314LE. Epub [PubMed PMID: 30978302]
Level 3 (low-level) evidencePostolache P, Nemeş RM, Petrescu O, Merişanu IO. Smoking cessation, pulmonary rehabilitation and quality of life at smokers with COPD. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2015 Jan-Mar:119(1):77-80 [PubMed PMID: 25970946]
Heffner JE, Fahy B, Hilling L, Barbieri C. Outcomes of advance directive education of pulmonary rehabilitation patients. American journal of respiratory and critical care medicine. 1997 Mar:155(3):1055-9 [PubMed PMID: 9116986]
Level 1 (high-level) evidenceBolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker PP, Walmsley S, British Thoracic Society Pulmonary Rehabilitation Guideline Development Group, British Thoracic Society Standards of Care Committee. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013 Sep:68 Suppl 2():ii1-30. doi: 10.1136/thoraxjnl-2013-203808. Epub [PubMed PMID: 23880483]
Harada H, Yamashita Y, Misumi K, Tsubokawa N, Nakao J, Matsutani J, Yamasaki M, Ohkawachi T, Taniyama K. Multidisciplinary team-based approach for comprehensive preoperative pulmonary rehabilitation including intensive nutritional support for lung cancer patients. PloS one. 2013:8(3):e59566. doi: 10.1371/journal.pone.0059566. Epub 2013 Mar 15 [PubMed PMID: 23555043]